Efficaciously manage HIV infections with 3TC150mg+NVP200mg+AZT300mg Tablets. These film-coated tablets encapsulate a powerful mix of Lamivudine, Nevirapine, and Zidovudine, specifically tailored to hinder HIV virus replication. It is crucial to seek professional healthcare advice for their effective application. The product should not be taken during the initial 2 weeks of Nevirapine lead-in treatment.
3TC150mg+NVP200mg+AZT300mg Tablets are a groundbreaking solution for managing HIV infections. This robust blend of Lamivudine (150mg), Nevirapine (200mg), and Zidovudine (300mg) primarily targets the Nucleoside Reverse Transcriptase, a process crucial for the life cycle of HIV. Effectively impairing the virus's ability to replicate, this product is globally renowned for its efficacy in combating HIV.
Fight HIV more efficiently with our 3TC150mg+NVP200mg+AZT300mg Tablets. This innovative blend of Lamivudine, Nevirapine, and Zidovudine, suitable for both children and adults, offers an all-encompassing approach to managing HIV. This medication utilises its properties as a Nucleoside Reverse Transcriptase Inhibitor (NRTI) to inhibit the reverse transcription process of HIV, ensuring effective relief and strengthening the immune system over time.